MedPath

A Single-Blinded, Randomized, Split-Face Study of Efficacy and Safety Using Fractional Picosecond 1064 nm Nd:YAG Compared to Fractional 1550 nm Ytterbium/Erbium Fiber Laser in Facial Rejuvenation and Treatment of Dilated Pores in Asia

Phase 4
Recruiting
Conditions
dilated pores&#44
facial aging&#44
fine wrinkles
Registration Number
TCTR20171130003
Lead Sponsor
Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

1.Age between 35 †50 year-old
2.No history of photo allergy
3.Compatible with follow-up schedule
4.Informed consent

Exclusion Criteria

1.Pregnancy or Giving lactationตั้งครรภ์ หรือให้นมบุตร
2.Previously treated with rejuvenation energy-based devices within 3 months
3.Underlying diseases of autoimmune diseases
4.Wounds or severe cystic acne on the face
5.Presence of pre-existing skin diseases on the face
6.Patients with severe underlying diseases
7.Withdraw

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement score in wrinkles, pore size and pigmentary lesions Week 12, Week 16, Week 20 Visual analogue scores, evaluated by blinded dermatologists and patients,Pores volume Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 Visioscan,Transepidermal water loss Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 DermaLab® Combo,Pigmentary melanin index Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 Chromameter CR-200 Panasonic
Secondary Outcome Measures
NameTimeMethod
Adverse effects Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 Evaluated from patients and attending dermatologists,Patient satisfaction Week 12, Week 16, Week 20 Patients satisfaction rating score
© Copyright 2025. All Rights Reserved by MedPath